drugset / Trial / NCT00997542

Allopurinol in Chronic Heart Failure

NCT00997542

Phase 4 Completed 16 enrolled National Heart and Lung Institute
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to discover whether the inhibition of the xanthine oxidase with allopurinol leads to a reduction of the production of oxygen free radicals in patients with CHF and thereby improves characteristics of oxydative metabolism, peripheral blood flow, immune function and functional status.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Allopurinol Small molecule

Indications